Vaccinex, Inc. Financing Cash Flow
Vaccinex, Inc. (VCNX) reported Financing Cash Flow of $15.78 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2025-04-15
- Vaccinex, Inc. net cash provided by (used in) financing activities for the quarter ending 2024-12-31 was $2.13M, a 76.68% decline year-over-year.
- Vaccinex, Inc. net cash provided by (used in) financing activities for the quarter ending 2024-09-30 was $5.89M, a 342.04% increase year-over-year.
- Vaccinex, Inc. net cash provided by (used in) financing activities for the quarter ending 2024-06-30 was $1.69M, a 58.70% decline year-over-year.
- Vaccinex, Inc. net cash provided by (used in) financing activities for the quarter ending 2024-03-31 was $6.07M, a 200.30% increase year-over-year.
- Vaccinex, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $15.78M, a 4.88% decline from fiscal 2023.
- Vaccinex, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $16.59M, a 2.27% decline from fiscal 2022.
- Vaccinex, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $16.98M, a 27.22% decline from fiscal 2021.
- Vaccinex, Inc. net cash provided by (used in) financing activities for fiscal 2021 was $23.32M, a 36.55% decline from fiscal 2020.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $8.02M derived: sum of 2 quarters · filed 2025-04-15 | $9.71M derived: sum of 3 quarters · filed 2025-04-15 | $15.78M 10-K · filed 2025-04-15 | |
| 2024-09-30 | $5.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $7.58M derived: sum of 2 quarters · filed 2024-11-14 | $13.65M 10-Q · filed 2024-11-14 | $22.79M derived: sum of 4 quarters · filed 2025-04-15 | |
| 2024-06-30 | $1.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $7.76M 10-Q · filed 2024-08-14 | $16.90M derived: sum of 3 quarters · filed 2025-04-15 | $18.24M derived: sum of 4 quarters · filed 2025-04-15 | |
| 2024-03-31 | $6.07M 10-Q · filed 2024-05-15 | $15.21M derived: sum of 2 quarters · filed 2025-04-15 | $16.55M derived: sum of 3 quarters · filed 2025-04-15 | $20.64M derived: sum of 4 quarters · filed 2025-04-15 | |
| 2023-12-31 | $9.14M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $10.48M derived: sum of 2 quarters · filed 2025-04-15 | $14.57M derived: sum of 3 quarters · filed 2025-04-15 | $16.59M 10-K · filed 2025-04-15 | $12.45M 10-K · filed 2024-04-02 |
| 2023-09-30 | $1.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $5.42M derived: sum of 2 quarters · filed 2024-11-14 | $7.45M 10-Q · filed 2024-11-14 | $11.25M derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $4.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $6.11M 10-Q · filed 2024-08-14 | $9.91M derived: sum of 3 quarters · filed 2024-08-14 | $9.90M derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $2.02M 10-Q · filed 2024-05-15 | $5.82M derived: sum of 2 quarters · filed 2024-05-15 | $5.80M derived: sum of 3 quarters · filed 2024-05-15 | $5.79M derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $3.80M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-04-25 | $3.78M derived: sum of 2 quarters · filed 2024-04-25 | $3.77M derived: sum of 3 quarters · filed 2024-04-25 | $16.98M 10-K/A · filed 2024-04-25 | |
| 2022-09-30 | -$19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$37.00K derived: sum of 2 quarters · filed 2023-11-13 | $13.17M 10-Q · filed 2023-11-13 | $13.16M derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | -$18.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $13.19M 10-Q · filed 2023-08-14 | $13.18M derived: sum of 3 quarters · filed 2023-08-14 | $10.61M derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $13.21M 10-Q · filed 2023-05-15 | $13.20M derived: sum of 2 quarters · filed 2023-05-15 | $10.63M derived: sum of 3 quarters · filed 2023-05-15 | $10.63M derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$2.58M derived: sum of 2 quarters · filed 2023-03-31 | -$2.58M derived: sum of 3 quarters · filed 2023-03-31 | $23.32M 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$2.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$2.58M derived: sum of 2 quarters · filed 2022-11-14 | $23.33M 10-Q · filed 2022-11-14 | $23.22M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $25.91M 10-Q · filed 2022-08-15 | $25.79M derived: sum of 3 quarters · filed 2022-08-15 | $51.70M derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | $25.91M 10-Q · filed 2022-05-16 | $25.79M derived: sum of 2 quarters · filed 2022-05-16 | $51.70M derived: sum of 3 quarters · filed 2022-05-16 | $55.19M derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | -$115.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $25.80M derived: sum of 2 quarters · filed 2022-03-31 | $29.28M derived: sum of 3 quarters · filed 2022-03-31 | $36.76M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $25.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $29.39M derived: sum of 2 quarters · filed 2021-11-08 | $36.87M 10-Q · filed 2021-11-08 | $36.87M derived: sum of 4 quarters · filed 2021-11-08 | |
| 2020-06-30 | $3.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $10.96M 10-Q · filed 2021-08-16 | $10.96M derived: sum of 3 quarters · filed 2021-08-16 | ||
| 2020-03-31 | $7.48M 10-Q · filed 2021-05-17 | $7.48M derived: sum of 2 quarters · filed 2021-05-17 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $13.80M 10-K · filed 2021-03-31 | |||
| 2019-09-30 | $13.80M 10-Q · filed 2020-11-13 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $33.28M derived: sum of 2 quarters · filed 2020-03-09 | $37.00M derived: sum of 3 quarters · filed 2020-03-09 | $40.95M 10-K · filed 2020-03-09 | |
| 2018-09-30 | $33.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $37.00M derived: sum of 2 quarters · filed 2019-11-12 | $40.95M 10-Q · filed 2019-11-12 | $50.96M derived: sum of 4 quarters · filed 2019-11-12 | |
| 2018-06-30 | $3.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $7.68M 10-Q · filed 2019-08-14 | $17.68M derived: sum of 3 quarters · filed 2019-08-14 | $21.68M derived: sum of 4 quarters · filed 2019-08-14 | |
| 2018-03-31 | $3.96M 10-Q · filed 2019-05-15 | $13.96M derived: sum of 2 quarters · filed 2019-05-15 | $17.96M derived: sum of 3 quarters · filed 2019-05-15 | ||
| 2017-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $14.00M derived: sum of 2 quarters · filed 2019-03-13 | $23.97M 10-K · filed 2019-03-13 | ||
| 2017-09-30 | $4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $13.97M 10-Q · filed 2018-11-13 | |||
| 2017-06-30 | $9.97M 10-Q · filed 2018-08-14 |